| LY2801653 |
梅沙替尼 |
1206799-15-6 |
| Momelotinib |
莫洛替尼 |
1056634-68-4 |
| Edivoxetine |
Edivoxetine |
1194508-25-2 |
| Fruquintinib|HMPL-013 |
呋喹替尼 |
1194506-26-7 |
| MB-07133 |
VIBEGRON |
1190389-15-1 |
| (S)-2-(4-(1-(tert-butoxycarbonyl)piperidin-3-yl)phenyl)-2H-indazole-7-carboxylicacid |
(S)-2-(4-(1-(tert-butoxycarbonyl)piperidin-3-yl)phenyl)-2H-indazole-7-carboxylicacid |
1038916-08-3 |
| Niraparib |
尼拉帕尼 |
1038915-60-4 |
| MK-4827 (tosylate) |
(3S)-3-[4-[7-(氨基羰基)-2H-吲唑-2-基]苯基]哌啶对甲苯磺酸盐 |
1038915-73-9 |
| Capmatinib |
卡马替尼 |
1029712-80-8 |
| Suvorexant |
苏沃雷生 |
1030377-33-3 |
| (2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate |
4-[[[(1R,2S,5R)-6-羟基-7-氧代-1,6-二氮杂双环[3.2.1]辛烷-2-基]羰基]氨基]-1-哌啶羧酸叔丁酯 |
1174020-64-4 |
| AZD 4017 |
AZD 4017 |
1024033-43-9 |
| (S)-tert-butyl 3-(4-aMinophenyl)piperidine-1-carboxylate |
(3S)-3-(4-氨基苯基)-1-哌啶甲酸叔丁酯 |
1171197-20-8 |
| 3-(4-((1R,2S)-1-(4-chlorophenyl)-1-(7-fluoro-5-methyl-1H-indol-3-yl)pentan-2-yl)benzamido)propanoicacid |
化合物 T28057 |
1019112-29-8 |
| LX-4211 |
索格列净 |
1018899-04-1 |
| VX-661 |
VX-661 |
1152311-62-0 |
| MK-5108 (VX-689) |
MK-5108 (VX-689) |
1010085-13-8 |
| GDC-0068 |
帕他色替 |
1001264-89-6 |
| tert-Butyl (R)-4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate |
(R)-4-(5-甲基-7-氧代-6,7-二氢-5H-环戊烷并[D]嘧啶-4-基)哌嗪-1-羧酸叔丁酯 |
1001180-21-7 |
| PF 04447943 |
PF 4447943 |
1082744-20-4 |
QQ
微信
